» Authors » C E Depuydt

C E Depuydt

Explore the profile of C E Depuydt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 510
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanherpe P, Fieuws S, DHondt A, Bleyenheuft C, Demaerel P, De Bleecker J, et al.
Orphanet J Rare Dis . 2020 Apr; 15(1):83. PMID: 32248831
Background: Late-onset Pompe disease (LOPD) is a rare, hereditary, progressive disorder that is usually characterized by limb-girdle muscle weakness and/or respiratory insufficiency. LOPD is caused by mutations in the acid...
2.
Depuydt C, Donders G, Verstraete L, Vanden Broeck D, Beert J, Salembier G, et al.
Facts Views Vis Obgyn . 2019 Aug; 10(4):201-205. PMID: 31367292
HPV is well known as a potential cause of cervical cancer. Less well known is its link to temporal subfertility that is caused by binding of infectious virions to the...
3.
Depuydt C, Beert J, Bosmans E, Salembier G
Facts Views Vis Obgyn . 2017 Feb; 8(4):211-222. PMID: 28210481
In the natural history of HPV infections, the HPV virions can induce two different pathways, namely the infec- tious virion producing pathway and the clonal transforming pathway. An overview is...
4.
Tjalma W, Depuydt C
Eur J Gynaecol Oncol . 2014 Apr; 35(2):117-20. PMID: 24772911
Background: Due to cervical cancer screening the number of squamous cancer have declined. The number of adenocarcinomas (ADCs) does appear to be rising. ADCs are often missed and human papillomavirus...
5.
Tjalma W, Depuydt C
Eur J Obstet Gynecol Reprod Biol . 2013 Aug; 170(1):45-6. PMID: 23932300
Cervical cancer can and should be a historical disease. The reality, however, is that every year more than half a million women are diagnosed with cervical cancer and a quarter...
6.
Depuydt C, Benoy I, Beert J, Criel A, Bogers J, Arbyn M
J Clin Microbiol . 2012 Oct; 50(12):4073-7. PMID: 23052314
To be acceptable for use in cervical cancer screening, a new assay that detects DNA of high-risk human papillomavirus (hrHPV) types must demonstrate high reproducibility and performance not inferior to...
7.
DHauwers K, Depuydt C, Bogers J, Noel J, Delvenne P, Marbaix E, et al.
Vaccine . 2012 Sep; 30(46):6573-7. PMID: 22939906
Purpose: The prevalence of penile cancer varies between 1.5 (industrialized countries) and 4.5 per 100,000 men (non-industrialized countries). Predominant histological subtype is squamous cell carcinoma (SCC). Human papillomavirus (HPV) is...
8.
Boulet G, Horvath C, Berghmans S, Moeneclaey L, Duys I, Arbyn M, et al.
J Clin Pathol . 2008 Jan; 61(5):637-41. PMID: 18227140
Aims: Cervical cytology biobanking is a feasible concept in cervical pathology and could be an indispensable tool for fundamental and applied molecular biological research. PCR is a powerful molecular technique...
9.
Depuydt C, Boulet G, Horvath C, Benoy I, Vereecken A, Bogers J
J Cell Mol Med . 2007 Sep; 11(4):881-91. PMID: 17760847
The causal relationship between persistent infection with high-risk HPV and cervical cancer has resulted in the development of HPV DNA detection systems. The widely used MY09/11 consensus PCR targets a...
10.
Boulet G, Schrauwen I, SahebAli S, Horvath C, Depuydt C, Vereecken A, et al.
J Clin Pathol . 2007 Jul; 60(8):896-901. PMID: 17660333
Background: Human papillomavirus (HPV) plays a critical role in the carcinogenesis of squamous cervical carcinoma. Integration of viral DNA into the host genome is a major contributing factor to malignant...